KMT2D and diffuse large B-cell lymphoma of the central nervous system: Figure 3B illustrates the mutation schematic diagram of the KMT2D gene in its domain region. These results demonstrated that KMT2D might be a promising marker for prognosis assessment in patients with primary CNS DLBCL.